ISSUES OF DIAGNOSIS AND MANAGEMENT OF PATIENTS WITH NEUROENDOCRINE CELL HYPERPLASIA OF INFANCY

Autor: I.V. Kovalenko, D.A. Skobeev, M. Daniel-Abu, M.A. Zhestkova, V.V. Popova, A.Yu. Rtishchev, E.R. Samitova, S.V. Zaitseva, P.A. Frolov, Sh.A. Gitinov, A.A. Baychikova, I.K. Asherova, M.A. Karpenko, D.Yu. Ovsyannikov, S.V. Starevskaya, A.B. Malakhov, O.V. Kustova, E.S. Pavlova, E.E. Petryaykina, A.G. Talalaev, I.M. Osmanov, Dentistry named after A.I. Evdokimov, Moscow, Russia, O.G. Topilin
Rok vydání: 2020
Předmět:
Zdroj: Pediatria. Journal named after G.N. Speransky. 99:78-87
ISSN: 1990-2182
0031-403X
Popis: Neuroendocrine hyperplasia of infancy (NEHI) is an interstitial lung disease (ILD) of unknown etiology, which develops in infancy and manifests as persistent tachypnea Objective of the research: to summarize results of observations of patients with NEHI, including during the pandemic of a new coronavirus infectious disease (COVID-19) Materials and methods: clinical and follow-up observation, laboratory and instrumental examination, including lung biopsy, 52 children with NEHI aged from 21 days to 10 years Results: NEHI more often affects boys in the first 6 months of life;can be diagnosed on the basis of pediatric ILD-syndrome detection;specific CT signs, lung biopsy It is characterized by undulating course with increased respiratory failurec aused by acute respiratory viral infections, COVID-19;half of the patients need oxygen therapy
Databáze: OpenAIRE